Monroe et al v. Rauner et al

Filing 336

CORRECTION to PRELIMINARY INJUNCTION. Paragraph 2 of the Preliminary Injunction (Doc. 332 ) is corrected to reflect the correct testosterone level set forth by the Endocrine Society Hormone Guidelines for transgender females, which is testosterone of less than 50 nanograms/deciliter, not 15 nanograms/deciliter as erroneously stated in the Preliminary Injunction. Signed by Chief Judge Nancy J. Rosenstengel on 8/18/2021. (beb)

Case 3:18-cv-00156-NJR Document 336 Filed 08/18/21 Page 1 of 2 Page ID #8034

IN THE UNITED STATES DISTRICT COURT
FOR THE SOUTHERN DISTRICT OF ILLINOIS
JANIAH MONROE,
MARILYN MELENDEZ,
LYDIA HELÉNA VISION,
SORA KUYKENDALL, and
SASHA REED, individually and on
behalf of a class of similarly situated
individuals,
Plaintiffs,
v.

Case No. 3:18-CV-00156-NJR

STEVE MEEKS,
MELVIN HINTON, and
ROB JEFFREYS,
Defendants.

CORRECTION to PRELIMINARY INJUNCTION
ROSENSTENGEL, Chief Judge:
The Court has been advised of a typographical error in Paragraph 2 of the
Preliminary Injunction issued August 9, 2021 (Doc. 332). Specifically, the correct
testosterone level set forth by the Endocrine Society Hormone Guidelines for transgender
females

is

for

testosterone

of

less

than

50

nanograms/deciliter,

not

15

nanograms/deciliter as erroneously stated in the Preliminary Injunction.
Accordingly, Paragraph 2 of the Preliminary Injunction (Doc. 332) is corrected as
follows:
2. Each member of the Plaintiff class who is currently receiving hormone
therapy shall, within 14 days of the date of this Order [August 9, 2021], be
given blood tests to assess hormone levels, as well as potassium, creatinine,
and prolactin levels (for transgender females) and hemoglobin/hematocrit

Case 3:18-cv-00156-NJR Document 336 Filed 08/18/21 Page 2 of 2 Page ID #8035

levels (for transgender males). Thereafter, if the hormone levels are not
within the appropriate range set forth by the Endocrine Society Hormone
Guidelines (for transgender females, testosterone of less than 50
nanograms/deciliter and estradiol between 100-200 picograms/milliliter;
for transgender males, testosterone levels between 400-600
nanograms/deciliter), Defendants shall ensure that the individual’s
hormone medication is titrated following receipt of the bloodwork results
and bloodwork repeated at least every 3 months until the levels are within
an appropriate range.
All other portions of the Preliminary Injunction (Doc. 332) remain in force, as
does the previous Preliminary Injunction (Doc. 212).
IT IS SO ORDERED.
DATED: August 18, 2021
____________________________
NANCY J. ROSENSTENGEL
Chief U.S. District Judge